Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for molecular diagnostics and POCT testing
3.2.1.2 Advancement in PCR technologies
3.2.1.3 Increasing prevalence of infectious diseases and genetic disorders
3.2.1.4 Increasing research and development activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of PCR devices
3.2.2.2 Dearth of trained experts
3.3 Growth potential analysis
3.4 Future market trends
3.5 Technological landscape
3.6 GAP analysis
3.7 Regulatory landscape
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits & reagents
5.3 Consumables
5.3.1 PCR tubes
5.3.2 PCR microplates
5.3.3 Cap/lids
5.3.4 Other consumables
5.4 Instruments
5.5 Software & services
Chapter 6 Market Estimates and Forecast, By Technique, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Conventional PCR
6.3 Real-time PCR
6.4 Digital PCR
6.5 Reverse transcription PCR
6.6 Hot-start PCR
6.7 Multiplex PCR
6.8 Other techniques
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Gene expression analysis
7.3 Genetic sequencing
7.4 Genotyping
7.5 Nucleic acid detection
7.6 Nucleic acid synthesis
7.7 Standard validation/ verification
7.8 Diagnostic application
7.9 Other applications
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals & diagnostic centers
8.3 Research & academics institutes
8.4 Pharma & biotech companies
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Agilent Technologies, Inc.
10.3 bioMérieux S.A.
10.4 Bio-Rad Laboratories, Inc
10.5 Danaher Corporation
10.6 Eppendorf SE
10.7 F. Hoffmann-LA Roche Ltd.
10.8 Illumina, Inc.
10.9 Merck KGaA
10.10 New England Biolabs
10.11 Promega Corporation
10.12 QIAGEN N.V.
10.13 Standard Biotools Inc.
10.14 Takara Holdings Inc.
10.15 Thermo Fisher Scientific Inc.
